Hepatotoxicity from Cimicifuga racemosa? Recent Australian case report not sufficiently substantiated

Journal of Alternative and Complementary Medicine

Volumn 9, Issue 3, 2003, Pages 337-340

  Thomsen, Michael ^a   Schmidt, Mathias ^b  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; NON PRESCRIPTION DRUG; PLANT EXTRACT;

ARTICLE; DRUG SURVEILLANCE PROGRAM; ESTROGEN THERAPY; HERBAL MEDICINE; LIVER TOXICITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SUBSTITUTION THERAPY;

EID: 0037674910     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/107555303765551552     Document Type: Article

References (20)

1. Awang DVC. Siberian ginseng toxicity may be case of mistaken identity. Can Med Assoc J 1996;155:1237.
2. Boblitz N, Liske E, Wüstenberg P. Black cohosh: Efficacy, effects, and safety of Cimicifuga racemosa in gynecology [in German]. Dtsch Apoth Ztg 2000;140:2833-2838.
3. Corrigan D. Adverse reports: Some first principles. Eur Phytojournal 2001;1.
4. D'Arcy PF. Adverse reactions and interactions with herbal medicines. Part 1: Adverse reactions. Adverse Drug React Toxicol Rev 1991;10:189-208.
5. Fasel-Felley J, Peitrequin R, Frei PC. Absence of circulating HBsAg in acute hepatitis B. Infection 1984;12:202-204.
6. Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134-138.
7. Huxtable RJ. The myth of beneficient nature: The risks of herbal preparations. Ann Intern Med 1992;117:165-166.
8. Laliberté L, Villeneuve JP. Hepatitis after the use of germander, a herbal remedy. Can Med Assoc J 1996;154:1689-1692.
9. Liebermann S. A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Women Health 1998;7:525-529.
10. Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv Ther 1998;15:45-53.
11. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal remedies. BMJ 1989;299:1156-1157.
12. Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL. Progression rate of Chinese herb nephropathy: Impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 2002;17:408-412.
13. McGuffin M, Hobbs C, Upton R, Goldberg A. American Herbal Product Association's Botanical Safety Handbook. Boca Raton, FL, CRC Press, 1997:105-106.
14. Miskelly FG, Goodyer LI. Hepatic and pulmonary complications of herbal medicines. Postgrad Med J 1992;68:935.
15. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-1692.
16. Schilcher H, Heil BM. Nephrotoxicity of preparations from juniper berries [in German]. Z Phytother 1994;15:205-213.
17. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002;22:195-206.
18. Violon C. Belgian (Chinese herb) nephropathy: Why? J Pharm Belg 1997;52:7-27.
19. Walker AM. The occurence of new hepatic disorders in a defined population. Post Marketing Surveillance 1992;1:107-111.
20. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002;177:440-443.